"PriMED Clinical Research (PCR) is a medical research organization that enables clinical trials. PriMED Clinical Research is a service of PriMED Physicians, an independent medical group with offices across Dayton and the Miami Valley."

During the past decade, PriMED Clinical Research conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 16 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PriMED Clinical Research" #1 sponsor was "Pfizer" with 10 trials, followed by "BioNTech SE" with 3 trials sponsored, "Sucampo Pharma Americas, LLC" with 3 trials sponsored, "Arrowhead Pharmaceuticals" with 2 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PriMED Clinical Research" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Sucampo AG" with 2 trials as a collaborator, "Takeda" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PriMED Clinical Research" are "Constipation - Functional" (3 trials), "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "SARS-CoV-2 Infection" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "PriMED Clinical Research" in a lesser frequency.

Most popular intervention types in "PriMED Clinical Research" are "Drug" (14 trials), "Biological" (12 trials), "Other" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Lubiprostone" (3 trials), "ARO-APOC3" (2 trials), "BNT162b2" (2 trials) and "Gan & Lee Insulin Glargine Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "PriMED Clinical Research" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PriMED Clinical Research". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in PriMED Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PriMED Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".